Shriram AMC Appoints Prateek Nigudkar as Senior Fund Manager

Shriram Asset Management Company Ltd. (Shriram AMC) has announced the appointment of Prateek Nigudkar as its new Senior Fund Manager. This move comes as part of the company’s efforts to boost its investment team and build innovative strategies for its mutual fund offerings.

About Parteek Guhad

Nigudkar brings over 13 years of experience in equity research, fund management, and asset allocation. He recently worked at Jio BlackRock Mutual Fund, where he was part of the equity investments team and helped shape the overall investment strategy.

Before that, he spent seven years at DSP Mutual Fund, where he managed a range of strategies—including quantitative, fundamental, and asset allocation funds. He also contributed by designing investment models that combined data science with detailed company research.

His career started at Credit Suisse, where he worked as a Quant and Thematic Research Analyst for more than five years. In that role, he built tools and provided insights for clients.

Prateek Nigudkar to Focus on Quantamental Investment Approach

At Shriram AMC, Nigudkar will focus on portfolio management and developing investment strategies. He will work on areas that combine quantitative models (using data and algorithms) with fundamental research (studying company details)—an approach known as "Quantamental".

Kartik Jain, MD & CEO of Shriram AMC, said, “We are excited to welcome Prateek. His expertise fits perfectly with our Quantamental philosophy and will help us create unique investment solutions.”

Prateek Nigudkar’s Educational Background

Nigudkar holds a Master’s degree in Quantitative Finance from the Olin Business School at Washington University in St. Louis. He has also cleared all levels of the CFA and FRM programs.

His appointment comes soon after Sanlam, South Africa’s largest asset manager, invested ₹105 crore in Shriram AMC in May 2025. With this backing, the company aims to strengthen its talent pool and investment capabilities.

Read more: Sun Pharma Share Price Rises 2%; Launches LEQSELVI in U.S. After Patent Settlement with Incyte.

Conclusion

With Prateek Nigudkar’s appointment, Shriram AMC continues to build a strong foundation for future growth. His knowledge in both data-driven and research-based strategies is expected to help the AMC deliver better investment outcomes for investors.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.